npj Women's Health, Published online: 31 October 2026; doi:10.1038/s44294-026-00168-1 Menstrual tracking app use in menstrual health management: a cross-sectional survey of user concerns, goals, and strategies
Amanda A. Shea, Kirsten Weber, Cornelia Hainer, Marta Gómez Vargas, Virginia J. Vitzthum. Menstrual tracking app use in menstrual health management: a cross-sectional survey of user concerns, goals, and strategies. // npj Women's Health. – 2026. – DOI: 10.1038/s44294-026-00168-1. – URL: https://www.nature.com/articles/s44294-026-00168-1
Amanda A. Shea, Kirsten Weber, Cornelia Hainer, Marta Gómez Vargas, & Virginia J. Vitzthum (2026). Menstrual tracking app use in menstrual health management: a cross-sectional survey of user concerns, goals, and strategies. npj Women's Health. https://doi.org/10.1038/s44294-026-00168-1
Amanda A. Shea, et al. “Menstrual tracking app use in menstrual health management: a cross-sectional survey of user concerns, goals, and strategies.” npj Women's Health, 2026. doi:10.1038/s44294-026-00168-1.
@article{Shea2026,
title = {Menstrual tracking app use in menstrual health management: a cross-sectional survey of user concerns, goals, and strategies},
author = {Shea, Amanda A. and Weber, Kirsten and Hainer, Cornelia and Vargas, Marta Gómez and Vitzthum, Virginia J.},
journal = {npj Women's Health},
year = {2026},
doi = {10.1038/s44294-026-00168-1},
url = {https://www.nature.com/articles/s44294-026-00168-1}
}
Eye, Published online: 19 November 2026; doi:10.1038/s41433-026-05030-x Comment on: ‘Association of accelerometer-monitored physical activity with incident cataract: epidemiological and genetic evidence’
Eye, Published online: 19 November 2026; doi:10.1038/s41433-026-05032-9 NAION during incretin-based therapy: an optic nerve head still adapted to hypertension
Eye, Published online: 19 November 2026; doi:10.1038/s41433-026-05016-9 Comparing refractive errors in CACNA1F and CABP4 -associated disease in a UK cohort
Eye, Published online: 19 November 2026; doi:10.1038/s41433-026-05018-7 Comment on: ‘Determinants of regression kinetics in observed stage 3 retinopathy of prematurity without plus disease’